CD30/BerH2, epithelial membrane antigen (EMA), CD15 and CD45, in addition to other antibodies suitable for paraffin tissues, a great proportion of ALC lymphoma cases expressed the CD30+, CD45+, CDI5-, EMA-or + phenotypic profile, while in a comparable percentage of HD cases RS cells were found to express the CD30+, CD45-, CDI5+, EMA-antigenic profile. However, since co-expression of CD30, CD45 and CD15 antigens was encountered in a far from negligible fraction of cases, the application of new discriminating markers would be extremely helpful. In this regard, recent studies (18) (19) (20) (21) have demonstrated the great relevance of CD26 antigen expression in CD30 positive ALC lymphomas (19) and have substantiated the consistent immunodetection of CD40 molecule on RS cells of HD (18, 20, 21) . In this paper we would like to make a few comments on the diagnostic significance of the combined application of MAbs against two members of the tumor necrosis factor/nerve growth factor receptor superfamily, namely CD40 and its ligand (CD40L), and the CD26 molecule in these disorders.
CD40 antigen. CD40 is a 50-kDa glycoprotein ex-Lymphocyte Classic HD predominance (LP) HD Extensive immunophenotypic analysis has shown heterogeneous antigenic profiles on Reed-Sternberg (RS) cells (1) and there have been no convincing indications of RS cell-specific antigens. Based on such evidence, a combination of several markers, including activation antigens (CD30, CDI5, CD25, CD7l), HLA-related molecules (CD74, HLA-DR), and T and B cellassociated antigens, is currently employed for the immunodiagnosis of Hodgkin's disease (HD) in routine pathology practice (2) (3) (4) (5) (6) . The nodular variant of the lymphocyte predominance (LP) subtype of HD poses special diagnostic problems since the LP variants of RS cells usually express several B-cell markers (2, 5, 7, 8) but lack consistent staining with anti-CDl5 (8-10) and CD30 (2) monoclonal antibodies (MAbs) (see Table I ).
CD30 expression is not restricted to the RS cells of HD, as CD30 MAbs also identify a group of non-Hodgkin's lymphomas (NHL), designated anaplastic large cell (ALe) lymphomas (3) . In most cases, CD30positive ALC lymphomas exhibit considerable morphologic resemblance to HD (11) (12) (13) . Both conditions share several phenotypic and genotypic features and the existence of a continuum between these two types of neoplasia has been suggested (14) . The overlapping phenotypic features of HD and ALC lymphomas include the expression of the CD30 molecule and other activation antigens, and the inconsistent expression of T-or B-lineage antigens often leading to a "null-cell" overall phenotype (4, 11, 14, 15) . Expression of the HD-associated antigen BLA.36 in ALC lymphomas further supports a phenotypic relationship between HD and ALC lymphomas (16) . Such similarities, which also extend to "functional" parameters (such as the production of specific cytokines like interleukin-9 (17)) further suggest that these two lymphoma entities are biologically related, and enhance the diagnostic difficulties in distinguishing them (4) .
In a comparative study (5) aimed at assessing in situ reactivity of a combination of antibodies such as pressed on the surface of peripheral blood and tonsillar B-cells, in most B-cellleukemias, in a number of carcinomas, and on relatively few normal epithelial cells (22) (23) (24) (25) (26) (27) . In tissue sections of lymphoid organs anti-CD40 MAbs show pan-B reactivity and typically stain interdigitating reticulum cells and follicular dendritic cells (24, 27) .
Among the lymphoproliferative disorders, only putative HD neoplastic cells exhibit consistent immunoreactivity with anti-CD40 Mabs on paraffin-embedded tissue sections (18) ( Fig. 1 ). In this respect we have recently demonstrated that RS cells and their morphologic variants express the CD40 molecule in 100% of HD cases, irrespective of histologic subtypes and antigenic phenotypes (B, T, non B-non T). The staining pattern of RS cells with anti-CD40 MAbs is highly distinctive and easily recognizable, i.e. very intense on cell membranes, being associated with cytoplasmic reactivity, and with a strong dot-like pattern in the paranuclear area. Overall, these findings indicate that CD40 antigen expression is very valuable in the identification of RS cells in fixed and paraffin embedded material. In addition, anti-CD40 MAbs are of particular interest in identifying RS cell variants of nodular LP subtype.
Anti-CD40 MAbs also stain B-cell NHL, though inconsistently (18, 24, 27) : neoplastic B-cells show moderate to strong diffuse cytoplasmic staining (18) . Since the distinction between B-NHL and HD is usually established on histologic grounds and immunohistologic data including the differential expression of CD 15 and CD30, the potential expression of CD40 by both pathologic entities does not impede a reliable differential diagnosis.
2 Anti-CD40 MAbs are unreactive in all T-cell lymphomas other than CD30-positive ALC lymphomas (18, 20) , hence the possibility of using CD40 antigen expression to discriminate between HD and peripheral T-cell lymphomas (PTCL). It is known that some cases of HD mixed cellularity subtype can be difficult to differentiate from PTCL even on immunohistologic grounds, especially when RS cells display T-cell associated markers (2) . Therefore, the constant presence of CD40 in HD and its absence in T-cell NHL is crucial in discriminating between pleomorphic T-cell lymphomas and a fraction (about 30%) of mixed cellularity HD cases in which RS cells express T-cell-associated markers such as~F1 (TCR~), CD2, CD4, and CD3 (1,2). CD30-positive ALC lymphoma cells react with CD40 MAbs in about one third of the cases including those expressing B, T, and null phenotypes (18) . This finding further corroborates the evidence that part of this heterogeneous group of NHL exhibits a considerable phenotypic resemblance to HD (2, 5) . However, only a minor proportion (20%) of CD30-positive ALC lymphomas of T-or null-cell phenotype has been found to be reactive with anti-CD40 MAbs (20) . As a consequence, the different reactivity to CD40 and the unique pattern of staining of RS cells are important tools to distinguish HD from these entities. Such diagnostic aid is very important in controversial cases of T-cell ALC lymphomas with fibrosis and RS-like cells and lymphocyte depletion HD or RS-cell rich cases of nodular sclerosing RD, including its syncytial variant (13) . Further studies will have to confirm whether the absence of CD40 represents a further feature to exclude HD in the differential diagnosis of HD vs ALC lymphoma.
CD26 antigen. CD26 corresponds to the surface enzyme dipeptidyl peptidase IV (28) . Recently it has been shown that CD26 is identical to the adenosine deaminase (ADA) binding protein, which is a cell surface transporter for ADA, an enzyme critically involved in the proliferation and functional activation of Tlymphocytes. In humans, CD26 is primarily expressed by CD3+ medullary thymocytes and is also detectable on different functional subsets of resting and activated human peripheral T-cells. The role of this molecule in the regulation of lymphopoiesis has recently been emphasized (28) .
Evidence has been provided that CD26 is detectable in neoplastic cells of T-cell CD30-positive ALC lymphomas and in a limited proportion of other T-cell NHLs (19) . According to a recent study confirming the diagnostic significance of CD26 antigen expression in CD30-positive ALC lymphomas (29) , the combined application of anti-CD40 and anti-CD26 MAbs does provide an important additional aid in differentiating HD from CD30-positive ALC lymphomas because a CD26+/CD40-profile is restricted to the latter tumors (29) (Fig. 2) .
CD40 ligand. while CD40 has been extensively studied in B-and T-cell NHL/leukemias and HD, few reports on the expression of its ligand (CD40L) in reactive lymphoid tissues and in lymphoproliferative disorders have been published so far.
CD40L is transiently and predominantly expressed by activated CD4+ 'f-Iymphccytes and by a small proportion of CD8+ T-cells (30) (31) (32) . In frozen tissue sections from reactive human lymph nodes, expression of CD40L is restricted to small lymphocytes (33, 34) . These cells display a prominent dot-like pattern or granular paranuclear staining, whereas a small number of positive cells exhibit a membrane staining pattern. CD40L-positive cells are localized in the mantle zone and germinal center light zone of secondary follicles. Usually, numerous cells expressing CD40L are also immunodetected within the interfollicular and paracortical areas (33, 34) . In lymphoproliferative disorders, CD40L is constitutively expressed by neoplastic T-cells almost invariably displaying the CD4+/CD8-phenotype (34) (35) (36) . Conversely, anti-CD40L MAbs are unreactive in all HD and B-cell NHLs (34) . Thus in human lymphomas CD40L, as detected by immunohistochemistry, is preferentially expressed by a restricted subset of mature Tcell neoplasms, most of which with a CD4+ phenotype.
Furthermore, considering that RS cells of HD express CD40 but lack CD40L, our above reported findings indicate that the expression of CD40 and its ligand is mutually exclusive in human lymphomas. All these results, which may be particularly important in understanding lymphoid tumor growth, have potential clinical implications. For example, the constant expression of a CD40+/CD40L-phenotype in HD and its absence in PTCL, which in tum expresses a CD40-/CD40L+/phenotype, provide additional significant features in differentiating HD from PTCL (Table II) .
In conclusion, our recent investigations into the functional role of the CD40 molecule and its specific ligand CD40L have disclosed new interesting prospects for clinical application in lymphoproliferative disorders. The therapeutic relevance of both molecules is under scrutiny. Conversely, their immunodiagnostic importance in hematopathology can now be acknowledged.
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